Avastin

eye doctor opthalmology phoropter glasses eye disease vision
Biotech

Outlook's eye disease drug fails to match Lucentis, sinking stock

The biotech brushed off the failure, noting positive details and vowing to seek FDA approval, but investors were less sanguine about the setback.
Nick Paul Taylor Nov 27, 2024 8:40am
Lung model

Overcoming resistance to cancer I-O by targeting macrophages

Aug 11, 2021 2:00pm
brown mouse

Roche's I-O antibody triplet shows promise in mouse tumor models

Jan 2, 2020 9:00am
3D brain against purple background

VBL sees Avastin-VB-111 phase 3 combo flop in brain cancer

Mar 8, 2018 8:35am
St Pancras Renaissance London

Cancer Research UK in $63M clinical trial boost

Feb 15, 2018 3:49am
Ignyta CEO

Roche splashes $1.7B in cash for Ignyta and entrectinib

Dec 22, 2017 4:21am